GAD2 and type 1 diabetes mellitus: Since about 20 years ago, serum and CSF anti-GAD65 antibody titers and intrathecal production were measured in 24 SPS patients and 70 disease controls (including 11 with insulin-dependent diabetes mellitus) [18].